Loading company…
Meliora Therapeutics uses molecular data and machine learning to develop oncology drugs and identify drug mechanisms.
Founded in 2021, Meliora Therapeutics develops oncology drugs using molecular fingerprinting, machine learning and biology. Its AnchorOmics platform analyzes compounds to identify mechanisms of action and potential drug candidates. The company is based in Sacramento, US. In September 2022, it raised USD 11 million in seed funding co-led by HOF Capital and ZhenFund, with Axial VC, BrightEdge Ventures, Obvious Ventures, Olive Capital, Pebblebed and Village Global participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in